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The nearly 600 proteases in the human genome reg-
ulate a diversity of biological processes, including
programmed cell death. Comprehensive character-
ization of protease signaling in complex biological
samples is limited by available proteomic methods.
We have developed a general approach for global
identification of proteolytic cleavage sites using an
engineered enzyme to selectively biotinylate free pro-
tein N termini for positive enrichment of correspond-
ing N-terminal peptides. Using this method to study
apoptosis, we have sequenced 333 caspase-like
cleavage sites distributed among 292 protein sub-
strates. These sites are generally not predicted by
in vitro caspase substrate specificity but can
be used to predict other physiological caspase cleav-
age sites. Structural bioinformatic studies show that
caspase cleavage sites often appear in surface-
accessible loops and even occasionally in helical re-
gions. Strikingly, we also find that a disproportionate
number of caspase substrates physically interact,
suggesting that these dimeric proteases target pro-
tein complexes and networks to elicit apoptosis.
INTRODUCTION
Apoptosis is a noninflammatory form of cell death that regulates
tissue differentiation and homeostasis in higher eukaryotes (for
a review, see Taylor et al., 2008). Since apoptotic turnover of
cells lies in direct opposition to the uncontrolled growth of tumor
cells, a strong link exists between apoptosis and cancer. Indeed,
the terminal cellular effect of most chemotherapeutic com-
pounds is induction of apoptosis (Kaufmann and Earnshaw,
2000). The widespread intracellular proteolysis that is a hallmark
of apoptosis is predominantly mediated by a family of dimeric
aspartate-specific proteases termed caspases. Apoptosis can
be induced by extracellular death ligands, such as Fas ligand,866 Cell 134, 866–876, September 5, 2008 ª2008 Elsevier Inc.TNF-a, or TRAIL, via the extrinsic pathway to activate cas-
pase-8. It can also be induced by agents such as cytotoxic com-
pounds, radiation, and other environmental stresses via the
intrinsic pathway with release of proapoptotic factors from
mitochondria to activate caspase-9. Initiator caspases-8 and
-9 in turn activate executioner caspases, among them cas-
pases-3 and -7. Caspases then catalyze a multitude of proteo-
lytic events to inactivate prosurvival and/or antiapoptotic pro-
teins and activate antisurvival and/or proapoptotic proteins.
This proteolysis results in apoptotic cell death and clearance of
apoptotic bodies by phagocytes.
Because the study of apoptotic pathways has ramifications for
development of therapies for treatment of cancer, there is signif-
icant interest in gaining a better understanding of caspase activ-
ity during apoptosis. For example, identification of new targets of
proteolysis in apoptosis can lead to the discovery of prosurvival
and/or antiapoptotic factors, which can lead to identification of
chemotherapeutic targets. Over 300 publications describing
a wide variety of cell types and apoptotic inducers have reported
the proteolysis of approximately 360 human proteins in apopto-
sis (Lu¨thi andMartin, 2007). Adding to this complexity, the nature
of the apoptotic response varies widely in a cell-dependent and
stimulus-dependent manner that cannot be easily predicted
(Fulda et al., 2001; Stepczynska et al., 2001; Wiegand et al.,
2001). Thus, combined data sets of caspase substrates from
studies using varied inducers and cell types have limited use
for understanding how a single inducer can cause apoptosis in
a particular cell type.
We have developed an enzymatic approach for global profiling
of proteolysis and sequencing of cleavage sites in complex mix-
tures that is based on positive selection of protein fragments
containing unblocked a-amines, characteristically produced in
proteolysis. This positive selection is enabled by use of an engi-
neered peptide ligase termed subtiligase to selectively biotiny-
late unblocked protein a-amines with absolute selectivity over
3-amines of lysine side chains. We have used this method to se-
quence 333 cleavage sites in 292 different protein substrates tar-
geted by caspase-like proteolysis in Jurkat cells after intrinsic
induction of apoptosis with the classic chemotherapeutic
etoposide. In profiling the proteolysis that is induced by a single
Figure 1. A Subtiligase-Based Method for Positive Selection of Peptides Corresponding to N Termini of Proteins from Complex Mixtures
(A) Workflow for biotinylation of protein N termini in complex mixtures using subtiligase and a biotinylated peptide ester that contains a TEV protease cleavage
site, trypsinization of labeled proteins, capture of biotinylated N-terminal peptides with immobilized avidin, recovery of captured peptides with TEV protease, and
analysis of N-terminal peptides by 1D or 2D LC/MS/MS for identification of corresponding proteins and cleavage sites. The representative MS/MS spectrum
corresponds to semitryptic peptide GSAVNGTSSAETNLEALQK from MEK1 (MP2K1_HUMAN) and identifies a previously unknown caspase-like cleavage
site at Asp 16. The a2 and b2 ions at m/z 223 and 251 are characteristic hallmarks of a ligated, SY-bearing, N-terminal peptide.
(B) Structure of the biotinylated peptide glycolate ester used in the proteomic workflow.agent in a single cell line, this work reveals the vastness of cas-
pase-like proteolysis that takes place during apoptosis, sheds
light on determinants of specificity for this activity in a cellular
context, and demonstrates the utility of a powerful degradomic
technology to study proteolysis in biological samples.
RESULTS
A Degradomic Technology for Positive Selection
of Protease Substrates
Direct and selective labeling of protein a-amines or a-carboxyl-
ates is a powerful approach for profiling proteolysis in complex
mixtures since it permits direct identification of cleavage sites
in protein substrates. Approximately 80% of mammalian pro-teins are known to be N-terminally acetylated (Brown and
Roberts, 1976). Thus, greater signal over background can be
achieved through N-terminal instead of C-terminal labeling.
However, such labeling must still be extremely selective for a-
amines over lysine 3-amines, which are approximately 25 times
more abundant in an average protein. To achieve this selectivity,
we have adopted an enzymological approach that makes use of
the rationally designed protein ligase subtiligase. This engi-
neered enzyme exhibits absolute selectivity for modification of
a-amines (Abrahmse´n et al., 1991; Chang et al., 1994).
We have developed a proteomic method utilizing subtiligase
that enables capture and sequencing of N-terminal peptides
found in complex biochemical mixtures (Figure 1A). Proteins in
biological samples are N-terminally biotinylated by treatmentCell 134, 866–876, September 5, 2008 ª2008 Elsevier Inc. 867
with subtiligase and a peptide glycolate ester substrate specially
tailored to our proteomic workflow (Figure 1B). Biotinylated sam-
ples are exhaustively digested with trypsin, and N-terminal pep-
tides are captured with avidin affinity media. The peptide ester
substrate contains a tobacco etch virus (TEV) protease cleavage
site to permit facile recovery of captured peptides. An important
aspect of our workflow is that recovered peptides retain an
N-terminal SY-dipeptide modification, providing a key hallmark
to distinguish labeled peptides from contaminating unlabeled
peptides with tandem mass spectrometry (LC/MS/MS). In stan-
dard protease nomenclature, substrates are cleaved between
the P1 (N-terminal) and P10 (C-terminal) residues, with Pn and
Pn0 residues increasing in count by one in both directions away
from the scissile bond (Schechter and Berger, 1968). Thus, the
Pn0 residues of a cleavage site correspond to N-terminal resi-
dues of the labeled peptide identified, whereas the Pn residues
of a cleavage site can be inferred from the protein sequence
preceding the identified peptide.
As a validation of this method, we analyzed endogenous N
termini in nonapoptotic Jurkat cells in two small-scale experi-
ments using one-dimensional reversed-phase (1D) LC/MS/MS
and two large-scale experiments using two-dimensional strong
cation exchange/reversed-phase (2D) LC/MS/MS (summarized
in Tables S1 and S2 available online). Comparison of data ob-
tained in both types of experiments is informative since 1D LC/
MS/MS typically results in identification of abundant N termini,
whereas the increased proteomic coverage afforded by 2D LC/
MS/MS results in additional identification of lower-abundance
N termini. Of the combined 131 unique N termini identified in
small-scale experiments, 72% are either annotated in Swiss-
Prot as native protein N termini or correspond to cleavages
within the first 50 residues of proteins, as would be expected
for N-terminal signal or transit peptide processing (Figure S1A).
The remaining 28% correspond to cleavages outside of the first
50 residues, arising from additional processing or constitutive
protein degradation. In support of this notion, 51% of the com-
bined 661 unique N termini identified in large-scale experiments
correspond to cleavages outside of the first 50 residues
(Figure S1A). The increased frequency of such N termini in
large-scale experiments is consistent with the expected lower
abundance for products of constitutive protein degradation.
Degradomic Analysis of Apoptotic Jurkat Cells
For analysis of apoptosis in Jurkat cells, we conducted several
small-scale (1D) and large-scale (2D) LC/MS/MS experiments
(representatives are summarized in Tables S3 and S4) with cells
treated with the topoisomerase II poison etoposide. The experi-
ments with untreated cells described above serve as respective
controls for the small- and large-scale experiments with apopto-
tic cells, in which a combined 244 and 733 unique N termini, re-
spectively, were identified. Combined data sets of all N-terminal
peptides identified in untreated and apoptotic Jurkat cells, re-
spectively, are included as supplemental data (Tables S5 and
S6). Caspases are known to exhibit strict substrate specificity
for aspartate at P1, and for glycine > serine > alanine at P10
(Schilling and Overall, 2008; Stennicke et al., 2000). In small-
scale experiments, 43% of N termini identified in apoptotic cells
were derived from P1 aspartate cleavages, in contrast to less868 Cell 134, 866–876, September 5, 2008 ª2008 Elsevier Inc.than 1% in untreated cells (Figure 2A). In large-scale experi-
ments, 43%of N termini identified in apoptotic cells were derived
from P1 aspartate cleavages, in contrast to 3% in untreated cells
(Figure 2B). An increased frequency of glycine at the first position
of N termini is also observed in apoptotic cells relative to un-
treated cells at both experimental scales (Figures 2A and 2B).
The N termini uniquely identified in apoptotic Jurkat cells are
thus consistent with induction of caspase-like activity.
Of the 3% P1 aspartate N termini detected in large-scale ex-
perimentswith untreated cells (Figure 2B), 55%correspond to re-
ported caspase substrates (Lu¨thi and Martin, 2007). Thus, it is
likely that these originate from the small number of apoptotic cells
typically present in untreated cultures. The detection of 3% P1
aspartate N termini in large-scale experiments with untreated
cells and less than 1% in small-scale experiments is consistent
with the low abundance of such N termini in cultures of normal
cells. Additionally, if one considers that N termini annotated in
Swiss-Prot are representative of native N termini in healthy cells,
it is notable that less than 1% are derived from proteolytic
processing after an aspartate residue (Figure S2). In apoptotic
samples, we find that the increased frequency of N termini
located beyond the first 50 residues is solely attributable to P1
aspartate cleavages (FiguresS1BandS1C). Thus, the vastmajor-
ity of proteolysis we observe in apoptosis is attributable to cas-
pases or proteases with caspase-like substrate specificity.
Among the total 1099 SY-labeled peptides identified in etopo-
side-treated Jurkat cells, 418 follow aspartate in corresponding
protein sequences (Tables S4 and S6). These peptides corre-
spond to 333 P1 aspartate N termini and caspase-like cleavage
sites (identified cleavage sites are listed in Table S7). In turn,
these cleavage sites map to 282 unique substrates and ten ad-
ditional others that cannot be distinguished from homologs con-
taining the same identified N terminus (identified substrates are
listed in Table S8). The average overlap between data sets ob-
tained in separate experiments is 55% at the peptide level and
58% at the protein level (Figures S3A and S3B). Similar overlap
levels (67%) have been previously observed for replicate anal-
yses of complex mixtures of peptides with LC/MS/MS (Elias
et al., 2005). We have verified 16 of the proteins identified as cas-
pase substrates in our studies to be cleaved during apoptosis,
using immunoblotting (representative examples are included
as Figure S4A). We have also determined that the proteolysis
of a representative set of substrates is blocked by the broad-
spectrum caspase inhibitor Z-VAD(OMe)-fmk, consistent with
this proteolysis being caspase dependent (Figure S4B).
The most frequent residues at the P4, P3, P2, and P10 posi-
tions of the caspase-like cleavage sites identified in apoptotic
Jurkat cells are aspartate, glutamate, valine, and glycine, re-
spectively (Figure 3A). Thus, an averaged composite of these
cleavage sites indicates that the most common caspase activity
in apoptotic cells exhibits a specificity that is most similar to the
substrate specificity of executioner caspases-3 and -7, as deter-
mined with peptide substrates (Figure 3B) (Thornberry et al.,
1997). However, there are significant differences between the
cellular cleavage sites and the in vitro specificity profiles. Nota-
bly, the canonical DEVD cleavage site motif is found in less
than 1% of the caspase-like cleavage sites observed in apopto-
tic Jurkat cells, and the broader DXXD motif is still only found in
Figure 2. N Termini Derived from Caspase-like Proteolytic Processing Are a Hallmark of Apoptotic Cells
(A) Frequencies of P1 and P10 amino acid residues corresponding to nonhomologous N termini identified in small-scale 1D LC/MS/MS experiments with
untreated and apoptotic Jurkat cells. Data are represented as mean ± SD (n = 2 for untreated, and n = 4 for apoptotic).
(B) Frequencies of P1 and P10 amino acid residues corresponding to nonhomologousN termini identified in large-scale 2D LC/MS/MS experimentswith untreated
and apoptotic Jurkat cells. Data are represented as mean ± SD (n = 2 for untreated, and n = 3 for apoptotic).
‘‘’’ indicates lack of a putative P1 residue in cases where the P10 residue is an initiator methionine.22% of the identified cleavage sites (Figure 3D). A distinct differ-
ence in the composite cellular profile is the high frequency of
serine and threonine residues at P4, P3, and P2, which is not
observed in vitro for any of the caspases (Figure S5). Interest-
ingly, a composite of all reported human capase cleavage sites
and human orthologs of reported rodent caspase cleavage sites(Lu¨thi andMartin, 2007) is very similar to the Jurkat cellular profile
reported here (Figure 3C).
These observations suggest that caspase substrate specific-
ity determinedwith peptide substrates has limited value as a pre-
dictor of physiological caspase cleavage sites. To investigate the
predictive value of a large set of known physiological caspaseFigure 3. Substrate Specificity of the Cas-
pase-like Proteolytic Activity Induced in
Apoptotic Cells
(A) Sequence logo representation (Crooks et al.,
2004) of the frequency of amino acid residues in
the capase-like cleavage sites identified in apo-
ptotic cells.
(B) Sequence logo representation of the in vitro
substrate specificity of caspase-3 (Stennicke
et al., 2000; Thornberry et al., 1997).
(C) Sequence logo representation of the frequency
of amino acid residues in previously reported
capase cleavage sites.
(D) Frequency of P4-P1 motifs in the capase-like
cleavage sites identified in apoptotic Jurkat cells.
(E) ROC curves for predictive HMMs constructed
from three different cleavage site training sets
(Jurkat, literature, andmerged). Three representative
HMM score threshold values for the merged data
set are indicated (TPR, true-positive rate; FPR,
false-positive rate).Cell 134, 866–876, September 5, 2008 ª2008 Elsevier Inc. 869
Figure 4. Structural Determinants of Caspase Substrate Specificity
(A) Solvent accessibility (>33% surface area exposed) at each position of all known P4–P40 positions of caspase cleavage sites and each position of all eight
residue sequences containing aspartate in the fourth position found in PDB protein structures (control peptides). Differences between cleavage sites and control
peptides have associated p values < 0.001 by chi-square test.
(B) Sequence logo representations of secondary structure at each position of all known P4–P40 positions of caspase cleavage sites and each position of the con-
trol peptides described above. L, loop; A, a-helix; and B, b sheet. Differences between cleavage sites and control peptides have associated p values < 0.001 by
chi-square test.
(C) Distribution of secondary structure motifs for P4–P40 caspase cleavage sites and for the control peptides described above.
(D) Localization of caspase cleavage sites in substrates relative to functional domain boundaries annotated in Pfam compared to localization of all eight residue
sequences containing aspartate in the fourth position found in the human Swiss-Prot database (control peptides). Differences between cleavage sites and control
peptides have associated p values < 0.001 by chi-square test.cleavage sites, we constructed three profile hidden Markov
models (HMMs) using the cleavage sites identified in our studies,
previously reported cleavage sites, and the union of these two
data sets (a detailed description of this analysis is found in the
Supplemental Experimental Procedures). The accuracy of these
HMMs was estimated via jackknifing and plotted in a receiver
operator characteristic (ROC) plot, showing the true-positive
rate versus the false-positive rate at different HMM score thresh-
olds. Although all three HMMs predict caspase cleavage sites
relatively accurately, the HMM built from the merged substrate
set performed slightly better than those built from the individual
sets (Figure 3E). Its true-positive rate was 0.86 at the false-pos-
itive rate of 0.15, compared to the average true-positive rate of
0.84 at the false-positive rate of 0.17 for the other two HMMs.
Analysis of Structural Determinants of Caspase
Substrate Specificity
The combined data set of the 333 caspase cleavage sites iden-
tified in our work and the approximately 300 previously identified
caspase cleavage sites (Lu¨thi andMartin, 2007) allows an oppor-870 Cell 134, 866–876, September 5, 2008 ª2008 Elsevier Inc.tunity to expand our understanding of caspase substrate speci-
ficity from primary structure to the level of secondary and higher-
order structures. To accomplish this goal, wemapped the known
caspase cleavage sites onto experimentally determined atomic
structures in the Protein Data Bank (PDB) (Berman et al.,
2002), as well as comparative protein structure models in the
ModBase database (Pieper et al., 2006). Stringent filters were
applied so that only models likely to be sufficiently accurate for
the analysis were used.
We identified 18 cleavage sites in known structures and 116
sites in comparative models. Depending on P4 through P40 posi-
tion, between 60% to 80% of cleavage site residues are solvent
accessible, as defined by solvent exposure of greater than 33%
total surface area (Figure 4A). Averaged across P4 through P40,
cleavage site residues are 76% more exposed than a reference
control of all octapeptide sequences in the PDB containing an
aspartate residue at the fourth position. The type of secondary
structure was assigned using DSSP (Kabsch and Sander,
1983) for P4 through P40 positions. The frequency of secondary
structure types at each position reveals that caspases most
frequently cleave protein substrates at loops relative to the octa-
peptide reference control described above (Figure 4B). Surpris-
ingly, proteolysis at a-helical regions is not uncommon. Binning
of cleavage sites into secondary structure motifs reveals that al-
though an all-loop motif is the most common secondary struc-
ture motif, the second most common one is an all-helix motif
(Figure 4C). The finding that some cleavages occur at solvent in-
accessible and a-helical regions likely reflects structural dynam-
ics of these regions. Structural examples of cleavages identified
in our studies are included as supplemental data (Figure S6).
Analysis of the location of cleavage sites in caspase sub-
strates annotated in the Pfam database (Finn et al., 2006) indi-
cates that 46% of them are located within an annotated func-
tional domain, 38% are located between annotated domains,
and 16% are located at protein termini, either before the first
annotated domain or after the last (Figure 4D). This distribution
is relatively similar to the distribution of a reference control of
all octapeptide sequences in the human Swiss-Prot database
containing an aspartate residue at the fourth position. Thus, cas-
pases do not exhibit a strong preference for cleavage of sub-
strates either inside or outside functional domains. Caspase
cleavage sites are also evenly distributed over the length of pro-
tein substrates (data not shown).
Analysis of Protein-Protein Interactions between
Caspase Substrates
Upon inspection of the entire data set of caspase substrates, we
noted a number of instances where multiple proteins along a sin-
gle biochemical pathway, or in a single protein complex, are
targeted by caspases. For a more systematic analysis of this
property, we utilized data from three different protein interaction
databases (HPRD, IntAct, and MINT) to create a network of cas-
pase substrate protein interactors (Chatr-aryamontri et al., 2007;
Kerrien et al., 2007; Mishra et al., 2006). This network is made up
solely of the substrates identified in our studies, reported human
capase substrates, and human orthologs of reported rodent cas-
pase substrates (Lu¨thi and Martin, 2007) but excludes the cas-
pases themselves (binary interactions constituting this network
are listed in Table S9). A total of 415 interactors and 1253 inter-
actions were found among the merged human caspase sub-
strate data set of 602 proteins, for an average of 2.1 intra-data
set interactions per caspase substrate. Ten data sets of 602 ran-
domly chosen proteins from the protein interaction databases
had an average of 0.2 intra-data set interactions per protein.
This indicates a 10-fold enrichment in protein interactions be-
tween caspase substrates relative to randomly interacting pro-
teins (Figure 5A) (a detailed description of this analysis is found
in the Supplemental Experimental Procedures).
To determine which biological processes are preferentially tar-
geted by caspases during apoptosis, we used the BiNGO (Maere
et al., 2005) plugin of Cytoscape (Shannon et al., 2003) to findGO
biological process terms that are overrepresented relative to the
complete human GO annotation. We then focused on the 132
terms in the three deepest levels of the GO hierarchy to find the
ten most overrepresented GO terms and the substrates anno-
tated to those terms. This analysis yielded subnetworks of sub-
strates involved in regulation of transcription, transcription from
RNA polymerase II promoter, DNA repair, antiapoptosis, induc-tion of apoptosis, apoptotic mitochondrial changes, regulation
of translational initiation, DNA unwinding during replication,
endocytosis, and cell division (Figures 5B–5K). The regulation
of transcription GO term yielded the densest subnetwork, with
188 edges among 93 nodes (Figure 5B). In sharp contrast to
the other nine GO terms, the cell division GO term barely yielded
a network at all, with only two edges among 20 nodes (Figure 5K).
The N-CoR/SMRT Complex Is a Target of Caspase
Proteolysis during Apoptosis
To analyze whether multiple cleavages along a pathway or in
a complex occur at physiologically relevant rates, we focused
on the portion of the regulation of transcription subnetwork rep-
resenting N-CoR/SMRT transcriptional corepressor complex
components and interactors (Figures 6A and 6B). This complex
is involved in the recruitment of histone deacetylase activity to
chromatin, which leads to chromatin condensation and tran-
scriptional repression. Our studies identified N-CoR/SMRT com-
plex resident components N-CoR and TBLR1 (Karagianni and
Wong, 2007), as well as additional N-CoR/SMRT complex inter-
actors HDAC7 (Fischle et al., 2001), MINT/SHARP/SPEN (Shi
et al., 2001), and RBBP7/RbAp46 (Takezawa et al., 2007) as cas-
pase substrates (MS/MS spectra of N-terminal peptides corre-
sponding to cleavage sites in these proteins are included as
Figures S7–S14). We probed for cleavage of these proteins dur-
ing etoposide-induced apoptosis in Jurkat cells by immunoblot
in order to qualitatively determine extent of proteolysis in each
case.
N-CoR, TBLR1, HDAC7, and SHARP were all fully cleaved at
rates similar to those observed for hallmark substrates procas-
pase-3 and DFF45 (Figures 6C and 6D). This proteolysis also
tracked reasonably well with the time course for DNA fragmenta-
tion. In contrast, only partial proteolysis of RBBP7was observed,
suggesting it to be a possible bystander substrate (Figure 6D).
Although not detected in our proteomic studies, we predicted
the N-CoR homolog SMRT (Karagianni and Wong, 2007) to
also be a caspase substrate on the basis of high sequence sim-
ilarity to N-CoR cleavage sites. Indeed, SMRT was fully cleaved
during etoposide-induced apoptosis in Jurkat cells (Figure 6E).
The previously identified caspase substrate HDAC3 (Escaffit
et al., 2007), another N-CoR/SMRT complex component (Kara-
gianni and Wong, 2007), was also fully cleaved. Organization of
functional domains in these proteins indicates that proteolytic
processing at the cleavage sites identified in our studies likely re-
sults in inactivation of protein function by virtue of separating
functional domains from one another (Figure 7).
DISCUSSION
One of the most striking findings of this study is that caspase
substrates as a whole tend to physically interact with one or
more other caspase substrates, either in protein complexes or
networks. We interpret this as an indication that caspases target
a limited set of biological pathways to elicit programmed cell
death, as opposed to indiscriminately targeting the entire cellular
proteome. These data also suggest that caspases target protein
complexes that are hubs for cell viability in essential processes
such as transcription and that targeting of multiple componentsCell 134, 866–876, September 5, 2008 ª2008 Elsevier Inc. 871
in each complex is required for a full commitment to apoptosis. In
this regard, it is notable that active caspases are dimeric, which
is rare for proteases. A dimer is well equipped for semiprocessive
activity consistent with targeting multiple components of protein
complexes. Another reported example of targeted proteolysis
of a protein complex is the cleavage of SET, HMG-2, and
Figure 5. Network Analysis of Protein Interactions between Caspase Substrates
This analysis was applied to the substrates identified in this work and previously reported caspase substrates (Lu¨thi and Martin, 2007).
(A) Enrichment in protein-protein interactions between the 602 total caspase substrates relative to an equally sized reference control set of protein interactors
randomly selected from protein interaction databases. Data for the control set are represented as mean ± SD (n = 10).
(B–K) Caspase substrate protein interaction subnetworks encompassing substrates annotated to overrepresented GO biological process terms relative to the
entire human GO annotation. Substrates are labeled with gene symbols. Corrected p values, number of nodes, and number of edges are indicated in each case.872 Cell 134, 866–876, September 5, 2008 ª2008 Elsevier Inc.
Ape1, three components of the SET complex, by the cytotoxic
lymphocyte protease granzyme A (Lieberman and Fan, 2003).
Interestingly, granzyme A is also dimeric.
The discovery that several components of the N-CoR/SMRT
transcriptional corepressor complex are targets of caspase pro-
teolysis presents a remarkable example of multiple cleavages in
a single protein complex or pathway during apoptosis. Six pro-
teins that are part of, or interact with, the N-CoR/SMRT complex
are fully cleaved during etoposide-induced apoptosis in Jurkat
cells, including the corepressors N-CoR and SMRT themselves.
This finding was made possible by our large-scale discovery-
oriented proteomic approach, as opposed to a more typical fo-
cused hypothesis-driven approach. Inactivation of the N-CoR/
SMRT complex during apoptosis may achieve a result similar
to the effect of HDAC inhibitors, with decreased histone deace-
tylation leading to opening of chromatin and transcriptional
upregulation of proapoptotic genes (Bolden et al., 2006). Inter-
estingly, HDAC 7 has recently been implicated as a physiological
substrate of caspase-8, with its proteolytic inactivation leading
to upregulation of Nur77 (Scott et al., 2008).
Our studies indicate that a change in function of proteins tar-
geted by caspases during apoptosis must be rationalized by
one or occasionally a few cuts per protein. We have found that
caspase cleavages occur inside functional domains and be-
tween functional domains at approximately equal frequencies.
In either case, relatively stable products must be produced after
cleavage of the substrates since we detected them. Stability of
Figure 6. Analysis of Proteolysis of N-CoR/
SMRT Corepressor Complex Components
during Apoptosis in Jurkat Cells after Treat-
ment with 50 mM Etoposide
(A) Caspase substrate protein interaction subnet-
work encompassing components of the N-CoR/
SMRT corepressor complex (N-CoR, SPEN,
TBLR1, RBBP7, and HDAC7), and transcription
factors such as retinoic acid receptor, androgen
receptor, and SP1 (green, from this work; red,
from literature; and blue, in both data sets).
(B) Schematic representation of N-CoR/SMRT co-
repressor complex resident components and visit-
ing interactors (red label, resident component;
white label, visiting interactor; and black fill, target
of proteolysis in apoptosis).
(C) Time courses for the proteolysis of procas-
pase-3 and DFF35/45 and for oligonucleosomal
DNA fragmentation.
(D) Full cleavage of N-CoR, HDAC7, SHARP, and
TBLR1, and partial cleavage of RBBP7.
(E) Full cleavage of SMRT and of HDAC-3, a previ-
ously identified caspase substrate.
Black arrows indicate full-length proteins. Red
arrows indicate expected cleavage products for
cleavage at the sites identified in our studies
(cleavage products were not detected in all cases).
these products is also consistent with
the relatively strict P10 glycine, serine,
and alanine specificity we observe for
the cellular caspase-like activity, which
creates fragments conforming to the N-end rule (Varshavsky,
1992). In addition to functional disruption of the substrate pro-
tein, such cleavages may result in products that function as
dominant negatives. For example, in the case of the N-CoR
and SMRT corepressors, the C-terminal cleavage products
contain the CoRNR boxes known to interact with nuclear recep-
tors (Hu and Lazar, 1999). These proteolysis products could
thus inhibit interaction between N-CoR/SMRT and nuclear re-
ceptors.
By globally identifying caspase-like cleavage sites in the pro-
teome of apoptotic cells, this work presents a large-scale sub-
strate specificity profile of caspase processing of endogenous
proteins in intact cells. Importantly, this profile is influenced not
only by the primary structure of cleavage sites but also by solvent
accessibility, secondary and higher order protein structure, and
possibly posttranslational modifications of substrates (To¨zse´r
et al., 2003). Our finding that caspases often target proteins in
complexes underscores the value of studying determinants of
proteolysis under physiologically relevant conditions. The cas-
pase-like cleavage sites identified in apoptotic Jurkat cells likely
result from the action of several members of the caspase family
of proteases. Although the aggregate substrate specificity of
the observed caspase-like activity is most similar to the known
specificity of executioner caspases, in vitro studies of caspases
using peptides do not fully account for the observed cellular
specificity (Schilling and Overall, 2008; Stennicke et al.,
2000; Thornberry et al., 1997). Peptide-centric approaches areCell 134, 866–876, September 5, 2008 ª2008 Elsevier Inc. 873
best suited for determination of optimal protease substrate
specificity, invaluable in development of sensitive synthetic sub-
strates or potent inhibitors. In contrast, a protein-centric method
such as the one presented here is best suited for characteriza-
tion of endogenous proteolysis in biological samples.
This work indicates that the widely used primary structural de-
terminants of caspase in vitro substrate specificity are insuffi-
cient to predict physiological caspase cleavage sites. However,
the cellular cleavage sites we have identified significantly ex-
pand a data set that can be used to train algorithms for predict-
ing cleavage sites. Indeed, a proof of principle is provided by an
accurate prediction of caspase cleavage sites by our prelimi-
nary HMMs. In addition to demonstrating that caspase cleavage
sites are most commonly found in solvent accessible loop re-
gions, as shown for other proteases (Hubbard et al., 1991),
our analysis also indicates that a number of cleavage sites ap-
pear in partially solvent inaccessible regions and a helices.
This information could also be incorporated into predictive algo-
rithms. Finally, based on our protein interaction analysis, predic-
tive algorithms may also benefit from scoring that considers
physical interactions of candidate substrates with other cas-
pase substrates.
Common approaches for the study of proteolysis in complex
mixtures employ gel electrophoresis and mass spectrometry
for analysis of proteins in cells, typically identifying tens of protein
substrates at a time (Machuy et al., 2005). These approaches do
not usually identify specific cleavage sites. In contrast, modern
proteomic methods using positive enrichment of phosphory-
lated, glycosylated, or ubiquitinated polypeptides can lead to
the identification of hundreds or thousands of posttranslationally
modified sites on proteins (Collins et al., 2007; Peng et al., 2003;
Vosseller et al., 2006). However, selective captureof theproducts
of proteolysis is not facile. Gevaert et al. andMcDonald et al. have
reported methods for negative selection of N-terminal peptides,
while Timmer et al. have reported an approach for positive selec-
tion of N-terminal peptides (Gevaert et al., 2003;McDonald et al.,
2005; Timmer et al., 2007). These chemical approaches require
two consecutive and quasiorthogonal derivatization steps, the
first to block lysine 3-amines and the second to label terminal
a-amines. We believe the success of our method is based on
the advantage of achieving great selectivity for a-amines in a
single labeling step through use of the enzyme subtiligase.
Figure 7. Caspases Cleave Resident N-
CoR/SMRT Complex Components and Vis-
iting Interactors at Regions Leading to Sep-
aration of Functional Domains
Functional domain organization and candidate
caspase cleavage sites in SMRT and TBL1 are
similar to those indicated for the respective homo-
logs, N-CoR and TBL1R.
The incomplete overlap between
cleavage sites and protein substrates
identified in our separate experiments
is not uncommon for tandemmass spec-
trometric analysis of complex mixtures,
in which analysis of many species,
whether peptidic or not, precludes complete sampling (Elias
et al., 2005). The number of caspase substrates we have iden-
tified is thus likely smaller than the total number of caspase sub-
strates in apoptotic Jurkat cells. We identified 50 of approxi-
mately 361 previously reported human caspase substrates
and 50 of approximately 307 previously reported human cas-
pase cleavage sites (Figures S3C–S3E) (Lu¨thi and Martin,
2007). Incomplete proteomic sampling of caspase substrates
in our studies is likely an important contributor to the modest
overlap between the substrates we have identified and those
previously reported.
In addition to incomplete sampling, three additional factors
can contribute to the modest overlap with previously reported
substrates. First, only cleavage sites corresponding to N-termi-
nal semitryptic peptides 7 to 40 residues in length (without the
additional SY dipeptide label) are generally identified in our stud-
ies. With collision-induced dissociation (CID), fragmentation of
peptides below this range generally does not provide enough in-
formation for unambiguous matching to databases, and most
peptides above this range do not fragment efficiently. Approxi-
mately half of the 307 previously reported human caspase cleav-
age sites result in N-terminal semitryptic peptides that fall out-
side this range and would not be identified with our current
method (Figure S15). Second, each analytical method, whether
global or focused, will have its own associated biases and limita-
tions. For example, a limitation of the subtiligase labelingmethod
is that the enzyme cannot access protein N termini that are bur-
ied or occluded. Third, we employed a single apoptotic inducer
in a single cell line, using a single analysis method, whereas
the previously reported set of substrates comes from amultitude
of studies using varied inducers, cell types, and methods.
Although the data set of substrates we have identified is not
comprehensive, it doubles the number of known cleavage sites
in human targets of caspase-like proteolysis in apoptosis. The
study of apoptotic pathways has important ramifications for
identification of pathways that are critical for cellular homeosta-
sis, and for development of potential anticancer therapeutics. A
number of caspase targets are active or established drug targets
for treating cancer, including topoisomerase II, Bcl-2, Hdm2,
MEK1, and Akt, to name a few. Thus, it is possible that the list
of substrates we have identified includes new candidate chemo-
therapeutic targets. The products of caspase proteolysis may874 Cell 134, 866–876, September 5, 2008 ª2008 Elsevier Inc.
also serve as useful biomarkers for assessment of chemothera-
peutic efficacy, as demonstrated in the case of cytokeratin-18
for breast cancer (Olofsson et al., 2007). Along with MS-based
quantitation, the technology we describe should enable global
analysis of the apoptotic phenotype as a function of time, cellular
context, and type of induction. Finally, the technology should
also be broadly applicable for global sequencing of proteolytic
cleavage sites in other biological settings.
EXPERIMENTAL PROCEDURES
Preparation of Subtiligase and Peptide Ester Substrate
Subtiligase was recombinantly expressed in B. subtilis and purified essentially
as previously described (Abrahmse´n et al., 1991). The biotinylated peptide gly-
colate ester was synthesized by solid-phase peptide synthesis as described
for other subtiligase substrates (Braisted et al., 1997).
Cell Culture, Induction of Apoptosis, and Cell Lysate Preparation
Jurkat clone E6-1 (ATCC) cells at a density of 13 106 cells/ml were treatedwith
etoposide (50mM) for 0 or 12 hr prior to being harvested. Detergent lysateswere
preparedat a typical concentrationof 23108cells/ml (approximately 20mg/ml)
with buffered 1.0% Triton X-100 in the presence of protease inhibitors.
Sample Biotinylation, Denaturation, Reduction, Alkylation,
and Gel Filtration
Cell lysates were biotinylated by treatment with subtiligase (1 mM), biotiny-
lated peptide ester substrate (1 mM), and DTT (2 mM). Ligation reactions were
typically left to proceed at room temperature for 60 min. Samples were then
denatured, reduced, alkylated, and subjected to gel filtration for removal of
hydrolyzed peptide ester substrate.
Trypsinization and Recovery of Biotinylated Peptides
Filtered samples were subjected to solution digestion with sequencing grade
modified trypsin (Promega). Biotinylated N-terminal peptides were captured
from trypsinized samples with NeutrAvidin agarose (Pierce). Captured pep-
tides were recovered by treatment of agarose resin with recombinant TEV
protease (1 mM).
LC/MS/MS
N-terminal peptide samples were analyzed by one-dimensional reversed-
phase LC/MS/MS or two-dimensional strong cation exchange/reversed-
phase LC/MS/MS. In the latter case, samples were fractionated by offline
strong cation exchange chromatography with a 60 min gradient on a 2.1 3
200 mm PolySULFOETHYL Aspartamide column at a flow rate of 0.3 ml/min.
Reversed-phase chromatography of unfractionated or fractionated samples
was carried out with a 60 min gradient on a 75 mm 3 15 cm C18 column at a
flow rate of 350 nl/min. The capillary column was coupled to a QSTAR Pulsar,
QSTAR XL, or QSTAR Elite mass spectrometer (Applied Biosystems). For each
acquired MS spectrum, either the single or the two most intense multiply
charged peaks were selected for generation of CID spectra. A dynamic exclu-
sion window of 3 min was applied. CID spectra not included as supplemental
data will be made available upon request.
Interpretation of MS/MS Spectra
Data were analyzed with Analyst QS software, and MS/MS centroid peak lists
were generated with the Mascot.dll script. Data were searched against the
Swiss-Prot human database (March 2008 release) with Protein Prospector
5.0 (University of California, San Francisco). Peptide tolerances in MS and
MS/MSmodes were 100 ppm and 300 ppm, respectively. The digest protease
specified was trypsin, allowing for two missed cleavages and nonspecific
cleavage at N termini. An N-terminal SYmodification and cysteine carbamido-
methylation were specified as a fixed modifications, and methionine oxidation
was specified as a variable modification. Peptides with scores R 22 and ex-
pectation values% 0.05 were considered positively identified. False-discovery
rates for peptide identifications were estimated with a target-decoy strategy.Bioinformatics
Cleavage site prediction was performed with HMMer version 2.3.2 (Eddy,
1998). The training and testing substrate sets were obtained by a jackknife pro-
cedure from data for the cleavage sites identified in our work and those previ-
ously reported in the literature (Lu¨thi andMartin, 2007). Solvent accessible sur-
face area and secondary structure analysis of cleavage sites was carried out
on a set of experimentally determined structures from the Protein Data Bank
(Berman et al., 2002) and ‘‘good quality’’ comparative models from ModBase
(Pieper et al., 2006). Domain analysis was performedwith domain assignments
from the Pfam database, (Finn et al., 2006). Protein-protein interaction analysis
was carried out with data from the HPRD (Mishra et al., 2006), IntAct (Kerrien
et al., 2007), and MINT (Chatr-aryamontri et al., 2007) databases.
DNA Fragmentation
Fragmentation of whole cell DNAwas analyzed by agarose gel electrophoresis
with the Apoptotic DNA Ladder Kit (Roche).
Immunoblotting
Jurkat cells at a density of 13 106 cells/ml were treated with etoposide (50 mM)
for 0, 2, 4, 8, 12, and 24 hr prior to being harvested. Whole-cell lysates were
prepared at a concentration of 2 3 107 cells/ml with buffered 1.0% SDS in
the presence of protease inhibitors and sonication. Lysates were normalized
to a protein concentration of approximately 2 mg/ml prior to analysis by
SDS-PAGE andwestern blot. Utilized antibodies are listed in the Supplemental
Experimental Procedures.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, nine
tables, and fifteen figures and can be found with this article online at http://
www.cell.com/cgi/content/full/134/5/866/DC1/.
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